Alopecia Areata
Symptoms, Doctors, Treatments, Advances & More

Learn About Alopecia Areata

What is the definition of Alopecia Areata?

Alopecia areata is a common disorder that causes hair loss. "Alopecia" is a Latin term that means baldness, and "areata" refers to the patchy nature of the hair loss that is typically seen with this condition.

What are the causes of Alopecia Areata?

The causes of alopecia areata are complex and not well understood. A combination of factors likely underlies the disorder, including changes in many genes that function in the hair and skin and in the immune system.

How prevalent is Alopecia Areata?

Alopecia areata affects 1 in every 500 to 1,000 people in the United States. It is one of many recognized forms of alopecia; alopecia areata is the second most common form after androgenetic alopecia (male-pattern baldness in men and female-pattern baldness in women). Alopecia areata affects men and women equally, and it can occur in people of any ethnic background.

Is Alopecia Areata an inherited disorder?

The inheritance pattern of alopecia areata is unclear because multiple genetic and environmental factors appear to be involved. Overall, the risk of developing the condition is greater for first-degree relatives (such as siblings or children) of affected individuals than it is in the general population. People with alopecia areata are also more likely to have family members with other autoimmune disorders.

Who are the top Alopecia Areata Local Doctors?
Arash Mostaghimi
Elite in Alopecia Areata
Elite in Alopecia Areata

Brigham Dermatology Associates

221 Longwood Avenue 1st Floor Brigham And Women's At 221 Longwood Boston, 1st Floor Brigham And Women's At 221 Longwood, 
Boston, MA 
Languages Spoken:
English
Offers Telehealth

Arash Mostaghimi is a Dermatologist in Boston, Massachusetts. Dr. Mostaghimi is rated as an Elite provider by MediFind in the treatment of Alopecia Areata. His top areas of expertise are Alopecia Areata, Autosomal Recessive Hypotrichosis, Pyoderma Gangrenosum, and Cellulitis.

Wilma Bergfeld
Elite in Alopecia Areata
Dermatology
Elite in Alopecia Areata
Dermatology

Cleveland Clinic Main Campus

2049 East 100th Street, 
Cleveland, OH 
Experience:
66+ years
Languages Spoken:
English
Offers Telehealth

Wilma Bergfeld is a Dermatologist in Cleveland, Ohio. Dr. Bergfeld has been practicing medicine for over 66 years and is rated as an Elite provider by MediFind in the treatment of Alopecia Areata. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Graham-Little-Piccardi-Lassueur Syndrome, Alopecia Areata, Squamous Cell Skin Carcinoma, and Osteotomy.

 
 
 
 
Learn about our expert tiers
Learn More
David Norris
Elite in Alopecia Areata
Dermatology
Elite in Alopecia Areata
Dermatology

University Of Colorado Hospital

1665 Aurora Ct, 
Aurora, CO 
Languages Spoken:
English

David Norris is a Dermatologist in Aurora, Colorado. Dr. Norris is rated as an Elite provider by MediFind in the treatment of Alopecia Areata. His top areas of expertise are Alopecia Areata, Autosomal Recessive Hypotrichosis, Eosinophilic Fasciitis, and Female Pattern Baldness.

What are the latest Alopecia Areata Clinical Trials?
A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of Baricitinib in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Summary: The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hair loss) in children from 6 years to less than 18 years of age. The study is divided into 4 periods, a 5-week Screening period, a 36-week Double-Blind Treatment Period, an approximately 2-year Long-term Extension Period, and a 4-week Post-treatment Fol...

Match to trials
Find the right clinical trials for you in under a minute
Get started
CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry

Summary: Prospective observational registry focusing on an adolescent cohort diagnosed with severe alopecia areata,receiving routine care from dermatology providers. Visit schedules for patients will be determined by the provider in accordance with routine clinical care, and any prescriptions provided to patients will adhere to product availability and local prescribing guidelines/regulations in the countr...

Who are the sources who wrote this article ?

Published Date: June 01, 2018
Published By: National Institutes of Health